Activists and researchers complain about the charge for treatment imported from the US
The Competition Commission is investigating the price of US pharmaceutical manufacturer Gilead Science’s coronavirus treatment remdesivir and prices charged by generic firms to which it granted manufacturing licences after a complaint by activists and researchers.
Commission spokesperson Makunga Siyabulela said on Monday that the organisation received a request from non-profit organisation the Health Justice Initiative and Wits research unit Ezintsha to examine the price of remdesivir. “It is ... currently under investigation and remedies are likely to be behavioural and/or an administrative penalty, if there is a finding of a contravention,” he said.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
ARM pays dividend amid higher iron ore and PGM pricesHigher metal prices boosted African Rainbow Minerals, despite the Covid-19 pandemic.
Read more »
SANBS looking at blood plasma as possible COVID-19 treatmentAs researchers across the globe, including South Africa, do their bit to find a vaccine for COVID-19, SANBS is also partaking in trials.
Read more »
SA's COVID-19 death toll exceeds 14,000The health department reported 47 COVID-19 related deaths in the last 24 hours.
Read more »
238 more Covid-19 deaths recorded in SASouth Africa has recorded a cumulative total of 622 551 confirmed Covid-19 cases in the country.
Read more »
Growing out of the virus slump | CitypressPolicy analysts, economists, business and labour say government needs to come up with a strategy to unlock the country’s productivity potential for improved competitiveness and sustainable economic growth, writes Thuletho Zwane
Read more »
JSE may benefit from upbeat Chinese data on MondayData reinforces hopes world’s second-largest economy is recovering from Covid-19 pandemic
Read more »